2011Zhongguo quanke yixueRequires access

The Value of Differential Diagnosis by Serum CA19-9 between Benign and Malignant Jaundice

Zhang Dewei

Open publisher page 0 citations

Abstract

Objective To explore the value of differential diagnosis by serum CA19-9 combinatied with serum total bilirubin to distinguish benign and malignant obstructive jaundice.Methods 15 cases of CA19-9 above the normal of benign obstructive jaundice and 23 patients with malignant obstructive jaundice patients were monitored by the serum CA19-9 and total bilirubin before and after treatment to inuestigate the correlation of the two indexs.Results Serum CA19-9 of patients with benign obstructive jaundice significantly decreased after treatment,the difference was significant(P0.01);CA19-9 of patients with malignant obstructive jaundice was no significantly difference before and after treatment(P=0.067).There was a positive correlation between the change of CA19-9 level and serum total bilirub in patients with benign obstructive jaundice before and after treatment(r=0.92 and 0.87,P0.01).However,there was no correlation in the malignant group(r=0.12 and 0.02,P=0.64 and 0.83).Conclusion Using CA19-9 levels of benign obstructive jaundice before and after treatment in patients with a significant difference,combined with positively correlation between CA19-9 and serum total bilirubin could distinguish benign from malignant obstructive jaundice.

About this research paper

What this paper is about

Objective To explore the value of differential diagnosis by serum CA19-9 combinatied with serum total bilirubin to distinguish benign and malignant obstructive jaundice.Methods 15 cases of CA19-9 above the normal of benign obstructive jaundice and 23 patients with malignant obstructive jaundice patients were monitored by the serum CA19-9 and total bilirubin before and after treatment to inuestigate the correlation of the two indexs.Results Serum CA19-9 of patients with benign obstructive jaundice significantly decreased after treatment,the difference was significant(P0.01);CA19-9 of patients with malignant obstructive jaundice was no significantly difference before and after treatment(P=0.067).There was a positive correlation between the change of CA19-9 level and serum total bilirub in patients with benign obstructive jaundice before and after treatment(r=0.92 and 0.87,P0.01).However,there was no correlation in the malignant group(r=0.12 and 0.02,P=0.64 and 0.83).Conclusion Using CA19-9 levels of benign obstructive jaundice before and after treatment in patients with a significant difference,combined with positively correlation between CA19-9 and serum total bilirubin could distinguish benign from malignant obstructive jaundice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the value of differential diagnosis by serum CA19-9 combinatied with serum total bilirubin to distinguish benign and malignant obstructive jaundice.Methods 15 cases of CA19-9 above the normal of benign obstructive jaundice and 23 patients with malignant obstructive jaundice patients were monitored by the serum CA19-9 and total bilirubin before and after treatment to inuestigate the correlation of the two indexs.Results Serum CA19-9 of patients with benign obstructive jaundice significantly decreased after treatment,the difference was significant(P0.01);CA19-9 of patients with malignant obstructive jaundice was no significantly difference before and after treatment(P=0.067).There was a positive correlation between the change of CA19-9 level and serum total bilirub in patients with benign obstructive jaundice before and after treatment(r=0.92 and 0.87,P0.01).However,there was no correlation in the malignant group(r=0.12 and 0.02,P=0.64 and 0.83).Conclusion Using CA19-9 levels of benign obstructive jaundice before and after treatment in patients with a significant difference,combined with positively correlation between CA19-9 and serum total bilirubin could distinguish benign from malignant obstructive jaundice.

Key concepts: Medicine, Obstructive jaundice, Jaundice, Gastroenterology, Internal medicine, Differential diagnosis, CA19-9, Bilirubin

Related papers

Back to paper searchBrowse research topicsOriginal source
The Value of Differential Diagnosis by Serum CA19-9 between Benign and Malignant Jaundice — Research Paper | ScholarLens